Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, et al. Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival. Neuro Oncol. 2020;22(9):1359–67.
Article CAS PubMed PubMed Central Google Scholar
Fares J, Kanojia D, Cordero A, Rashidi A, Miska J, Schwartz CW, et al. Current state of clinical trials in breast cancer brain metastases. Neurooncol Pract. 2019;6(5):392–401.
PubMed PubMed Central Google Scholar
Kanojia D, Panek WK, Cordero A, Fares J, Xiao A, Savchuk S, et al. BET inhibition increases βIII-tubulin expression and sensitizes metastatic breast cancer in the brain to vinorelbine. Sci Transl Med. 2020;26:12558.
Moravan MJ, Fecci PE, Anders CK, Clarke JM, Salama AKS, Adamson JD, et al. Current multidisciplinary management of brain metastases. Cancer. 2020;126(7):1390–406.
Arvold ND, Lee EQ, Mehta MP, Margolin K, Alexander BM, Lin NU, et al. Updates in the management of brain metastases. Neuro Oncol. 2016;18(8):1043–65.
Article PubMed PubMed Central Google Scholar
Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020;30(16):R921–5.
Article CAS PubMed PubMed Central Google Scholar
Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020;5(1):28.
Article PubMed PubMed Central Google Scholar
Salimifard S, Masjedi A, Hojjat-Farsangi M, Ghalamfarsa G, Irandoust M, Azizi G, et al. Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer. Pathol Res Pract. 2020;216(5):152915.
Article CAS PubMed Google Scholar
LeBleu VS, Kalluri R. A peek into cancer-associated fibroblasts: origins, functions and translational impact. Dis Model Mch. 2018;11(4):dmm029447.
Bu L, Baba H, Yoshida N, Miyake K, Yasuda T, Uchihara T, Tan P, Ishimoto T. Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment. Oncogene. 2019;38(25):4887–901.
Article CAS PubMed Google Scholar
Gieniec KA, Butler LM, Worthley DL, Woods SL. Cancer-associated fibroblasts-heroes or villains? Br J Cancer. 2019;121(4):293–302.
Article PubMed PubMed Central Google Scholar
Özdemir BC, Pentcheva-Hoang T, Carstens JL, Zheng X, Wu CC, Simpson TR, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25(6):719–34.
Article PubMed PubMed Central Google Scholar
Wang WQ, Liu L, Xu HX, Luo GP, Chen T, Wu CT, et al. Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer. PLoS ONE. 2013;8(8):e71189.
Article CAS PubMed PubMed Central Google Scholar
Ariga N, Sato E, Ohuchi N, Nagura H, Ohtani H. Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast. Int J Cancer. 2001;95(1):67–72.
Article CAS PubMed Google Scholar
Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol. 2021;18(12):792–804.
Article CAS PubMed PubMed Central Google Scholar
Akanda MR, Ahn EJ, Kim YJ, Salam SMA, Noh MG, Kim SS, et al. Different expression and clinical implications of Cancer-Associated Fibroblast (CAF) markers in Brain Metastases. J Cancer. 2023;14(3):464–79.
Article PubMed PubMed Central Google Scholar
Park JY, Moon KS, Lee KH, Lim SH, Jang WY, Lee H, et al. Gamma knife radiosurgery for elderly patients with brain metastases: evaluation of scoring systems that predict survival. BMC Cancer. 2015;15:54.
Article PubMed PubMed Central Google Scholar
Lee KH, Ahn EJ, Oh SJ, Kim O, Joo YE, Bae JA, et al. KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers. Oncotarget. 2015;6(5):3240–53.
McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276–82.
Andre F, Berrada N, Desmedt C. Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients. Curr Opin Oncol. 2010;22(6):547–51.
Article CAS PubMed Google Scholar
Tang Y, Wang Y, Kiani MF, Wang B, Classification. Treatment strategy, and Associated Drug Resistance in breast Cancer. Clin Breast Cancer. 2016;16(5):335–43.
Giorello MB, Borzone FR, Labovsky V, Piccioni FV, Chasseing NA. Cancer-Associated fibroblasts in the breast Tumor Microenvironment. J Mammary Gland Biol Neoplasia. 2021;26(2):135–55.
Amornsupak K, Jamjuntra P, Warnnissorn M, Sa-Nguanraksa POC, Thuwajit D, Eccles P, Thuwajit SA. High ASMA(+) fibroblasts and low cytoplasmic HMGB1(+) breast Cancer cells predict poor prognosis. Clin Breast Cancer. 2017;17(6):441–452e2.
Article CAS PubMed Google Scholar
Primac I, Maquoi E, Blacher S, Heljasvaara R, Van Deun J, Smeland HY, et al. Stromal integrin α11 regulates PDGFR-β signaling and promotes breast cancer progression. J Clin Invest. 2019;129(11):4609–28.
Article CAS PubMed PubMed Central Google Scholar
Yamashita M, Ogawa T, Zhang X, Hanamura N, Kashikura Y, Takamura M, Yoneda M, Shiraishi T. Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome. Breast Cancer. 2012;19(2):170–6.
Paulsson J, Rydén L, Strell C, Frings O, Tobin NP, Fornander T, Bergh J, Landberg G, Stål O, Östman A. High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer. J Pathol Clin Res. 2017;3(1):38–43.
Article CAS PubMed Google Scholar
Bartoschek M, Oskolkov N, Bocci M, Lövrot J, Larsson C, Sommarin M, et al. Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. Nat Commun. 2018;9(1):5150.
Article PubMed PubMed Central Google Scholar
Wu SZ, Roden DL, Wang C, Holliday H, Harvey K, Cazet AS, et al. Stromal cell diversity associated with immune evasion in human triple-negative breast cancer. Embo J. 2020;39(19):e104063.
Article CAS PubMed PubMed Central Google Scholar
Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, et al. Fibroblast heterogeneity and immunosuppressive environment in human breast Cancer. Cancer Cell. 2018;33(3):463–479e10.
Article CAS PubMed Google Scholar
Kim HM, Jung WH, Koo JS. Expression of cancer-associated fibroblast related proteins in metastatic breast cancer: an immunohistochemical analysis. J Transl Med. 2015;13:222.
Article PubMed PubMed Central Google Scholar
Park SY, Kim HM, Koo JS. Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer. Breast Cancer Res Treat. 2015;149(3):727–41.
Article CAS PubMed Google Scholar
Jeon W, Jang BS, Jeon SH, Kim JH, Kim YJ, Kim SH, Kim CY, Han JH, Kim IA. Analysis of survival outcomes based on molecular subtypes in breast cancer brain metastases: a single institutional cohort. Breast J. 2018;24(6):920–6.
Article CAS PubMed Google Scholar
Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174–86.
Article CAS PubMed PubMed Central Google Scholar
Rajkumar VS, Shiwen X, Bostrom M, Leoni P, Muddle J, Ivarsson M, et al. Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing. Am J Pathol. 2006;169(6):2254–65.
Article CAS PubMed PubMed Central Google Scholar
Shinde AV, Humeres C, Frangogiannis NG. The role of α-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling. Biochim Biophys Acta Mol Basis Dis. 2017;1863(1):298–309.
Article CAS PubMed Google Scholar
Tschumperlin DJ, Lagares D. Mechano-therapeutics: Targeting Mechanical Signaling in Fibrosis and Tumor Stroma. Pharmacol Ther. 2020;212:107575.
留言 (0)